Scarica l'app Stockscreener
45.32
1.18%
0.53
Dopo l'orario di chiusura:
45.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SUPN Giù?
Forum
Previsione
Supernus Pharmaceuticals Inc Borsa (SUPN) Ultime notizie
Supernus (Nasdaq: SUPN) to join Piper Sandler 37th Conference fireside chat Dec. 2 - Stock Titan
How Supernus Pharmaceuticals Inc. stock benefits from tech adoptionJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Why Supernus Pharmaceuticals Inc. stock could benefit from AI revolutionQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
Understanding the Setup: (SUPN) and Scalable Risk - news.stocktradersdaily.com
Advanced analytics toolkit walkthrough for Supernus Pharmaceuticals Inc.Sell Signal & Expert Approved Trade Ideas - newser.com
Statistical indicators supporting Supernus Pharmaceuticals Inc.’s strengthJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Measuring Supernus Pharmaceuticals Inc.’s beta against major indices2025 Dividend Review & Technical Confirmation Trade Alerts - newser.com
Is Supernus Pharmaceuticals Inc. a candidate for recovery playJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
How Investors Are Reacting To Supernus Pharmaceuticals (SUPN) Raising 2025 Revenue Guidance Despite Net Losses - simplywall.st
Supernus at Jefferies Conference: Strategic Growth and Challenges By Investing.com - Investing.com Australia
SUPN: Strong CNS portfolio growth, supply challenges for Onapgo, and active business development focus - TradingView
What analysts say about Supernus Pharmaceuticals Inc stockTechnical Breakout Signals & Free Powerful Profit Generation - earlytimes.in
Long term hold vs stop loss in Supernus Pharmaceuticals Inc.2025 Macro Impact & Technical Confirmation Alerts - newser.com
Using data models to predict Supernus Pharmaceuticals Inc. stock movementJobs Report & Weekly Momentum Stock Picks - newser.com
How to monitor Supernus Pharmaceuticals Inc. with trend dashboardsWeekly Investment Summary & Community Consensus Stock Picks - newser.com
Why Supernus Pharmaceuticals Inc. stock remains undervaluedEarnings Growth Report & Free Fast Gain Swing Trade Alerts - newser.com
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London - The Manila Times
Supernus (NASDAQ: SUPN) fireside chat Nov. 17 at 9:30 a.m. EST; webcast available - Stock Titan
5 Must-Read Analyst Questions From Supernus Pharmaceuticals’s Q3 Earnings Call - Yahoo Finance
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2025 Earnings Call Transcript - MSN
3.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):